NIEMOLLER, ELISABETH,SILVESTRE, LOUISE,BOKA, GABOR,MIOSSEC, PATRICK
申请号：
CA2835265
公开号：
CA2835265A1
申请日:
2012.05.11
申请国别(地区):
CA
年份:
2012
代理人:
摘要：
The present invention refers to a pharmaceutical combination for use in glycemic control in diabetes type 2 patients. The combination comprises lixisenatide (AVEOOIO), a GLP-1 agonist and basal insulin.
